# FDG-PET/CT Imaging as Early Predictor of DP

> **NCT02476734** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 9 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** There is no intervention

## Key facts

- **NCT ID:** NCT02476734
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-02
- **Final completion:** 2018-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476734, "FDG-PET/CT Imaging as Early Predictor of DP". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02476734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*